283-2002 PLC HE 20x 2283-2002 PLC HE 20x 3
Figure 1. H&E, 20x.Figure 2. H&E, 20x.
283-2002 Ecadherin 20x283-2002 AR 20X
Figure 3. Loss of E-cadherin expression.Figure 4. Diffuse and strong positivity for AR.